UK markets close in 5 hours 41 minutes

GC Biopharma Corp. (006280.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
111,100.00-400.00 (-0.36%)
At close: 03:30PM KST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-26,631,783
-26,631,783
65,453,134
123,211,806
81,048,858
Depreciation & amortisation
75,899,000
75,899,000
65,096,000
55,904,000
48,791,000
Change in working capital
-100,319,000
-100,319,000
-8,862,000
-18,978,000
-81,913,000
Inventory
-69,234,000
-69,234,000
1,721,000
-14,919,000
-52,086,000
Other working capital
-131,464,311
-131,464,311
24,464,071
2,440,257
-65,421,558
Other non-cash items
27,522,349
27,522,349
14,958,207
11,190,000
9,391,449
Net cash provided by operating activities
-5,472,810
-5,472,810
119,154,311
125,978,949
35,973,501
Cash flows from investing activities
Investments in property, plant and equipment
-125,991,501
-125,991,501
-94,690,240
-123,538,692
-101,395,059
Acquisitions, net
-17,238,266
-17,238,266
-107,459,370
-78,773,191
-31,769,502
Purchases of investments
-49,235,463
-49,235,463
-48,008,722
-5,815,799
-99,214,334
Sales/maturities of investments
41,335,187
41,335,187
49,932,385
50,162,880
153,463,117
Other investing activities
-1,422,612
-1,422,612
-723,699
8,325,545
108,188,870
Net cash used for investing activities
-150,243,304
-150,243,304
-205,259,307
-132,077,425
29,684,195
Net change in cash
-55,659,679
-55,659,679
-80,694,469
-46,228,137
133,826,750
Cash at beginning of period
105,365,808
105,365,808
186,060,277
232,288,414
98,461,664
Cash at end of period
49,706,128
49,706,128
105,365,808
186,060,277
232,288,414
Free cash flow
Operating cash flow
-5,472,810
-5,472,810
119,154,311
125,978,949
35,973,501
Capital expenditure
-125,991,501
-125,991,501
-94,690,240
-123,538,692
-101,395,059
Free cash flow
-131,464,311
-131,464,311
24,464,071
2,440,257
-65,421,558